Why Did Spire Healthcare Group plc Shares Rise on 13 November 2026?

Spire Healthcare Group plc (LSE:SPI) shares rose 0.20% to 248p on 13 November 2026. The UK private hospital group remained in focus after publishing interim results for the six months ended 30 June 2026 on 30 September 2026.

The update highlighted growth in self-pay and private medical insurance, progress in primary care and improved cash flow.

Key Highlights

Sir David Sloman, Interim Chief Executive, said the results reflected the group's strength in self-pay and private medical insurance. Revenue was £792.7m, in line with the prior year, while Primary Care revenue rose 8.1% to £72.1m and its adjusted EBITDA increased 23.7% to £5.5m.

Adjusted free Cash Flow rose 35.3% to £20.7m from £15.3m, Capital Expenditure fell to £36.3m from £51.2m, and net bank Debt reduced to £337.8m from £356.7m. The group continues to target full-year adjusted EBITDA broadly in line with FY25.

About Spire Healthcare Group plc

Spire Healthcare is a leading independent healthcare group in the UK, with 38 hospitals and more than 55 clinics. It provides private, insured and NHS-funded care, alongside a primary care business.

The group serves patients who pay for treatment themselves, those with private medical insurance and NHS patients referred to its hospitals.

Private Pay and Insured Patients

Growth in self-pay and private medical insurance was a central theme of the update. Self-pay patients fund their own treatment, and insured patients are covered by a private policy, so both groups sit outside NHS commissioning and give the group a private revenue base.

The mix between private and NHS work is closely followed in the sector because it influences how hospital capacity is used across the year.

Primary Care and Efficiency

Primary Care continued to develop as a division, with higher revenue and a rise in adjusted EBITDA during the period. The division provides services in community settings and can feed patients into the hospital network.

The group also targets £30m of transformation savings, a programme designed to improve efficiency across its operations while maintaining patient care.

Full-Year Reference Points

For the year ended 31 December 2025, revenue was £1,579.8m, up 4.5%, and adjusted EBITDA was £268.6m. These figures form the base against which the FY26 target of broadly similar adjusted EBITDA is measured.

Investors often compare interim and full-year figures to understand how seasonality and timing of activity affect a hospital group.

Leadership

Sir David Sloman became Interim Chief Executive, and Debbie White became Chair on 5 September 2026. Leadership appointments are followed by investors because they shape strategy, capital allocation and relationships with NHS and insurance partners.

Management continues to focus on delivering the transformation programme and the group's strategic priorities.

Understanding Adjusted EBITDA and Free Cash Flow

Adjusted EBITDA shows Earnings before interest, tax, Depreciation and certain adjusting items, and it is widely used to compare the earning power of hospital groups independent of capital structure. Free cash flow shows the cash remaining after Investment in the business.

Net bank debt measures borrowings less cash, and a falling figure indicates that cash generation is being used to reduce borrowings.

Why the Update Matters for the Sector

Private healthcare providers are followed for their role in easing pressure on waiting lists and for the balance between self-pay, insured and NHS work. Growth in private pay shows how Demand is evolving alongside NHS capacity.

The update also shows how cash discipline and capital spending choices can support a hospital group's Balance Sheet during a period of leadership change.

Key Growth Catalysts

Private pay growth, primary care expansion and the transformation savings give the group several routes to support earnings. Lower capital expenditure and higher free cash flow support the balance sheet.

Factors to Monitor

NHS funding and activity levels can influence hospital volumes, and cost Inflation affects margins across the sector. Timing of savings delivery will be important.

What Investors Should Watch Next

Investors may wish to follow progress against the FY26 EBITDA target, free cash flow, net bank debt and the pace of private pay growth.

Conclusion

Spire Healthcare Group plc (LSE:SPI) rose 0.20% to 248p on 13 November 2026. Spire reported growth in private pay, primary care progress and improved cash flow, with full-year EBITDA targeted broadly in line with FY25. Cash flow and private pay trends are the main items to follow.